Gestational trophoblastic tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All cases were clinically or histologically diagnosed as GTN; v did not receive chemotherapy, radiotherapy and concurrent chemoradiotherapy before admission; v all patients have no other immune system diseases and no history of other tumors; v patients are willing and able to provide written informed consent before participating in this study; v women in childbearing period with informed consent; If any of the inclusion criteria is "no", the patient cannot participate in the experiment.
Exclusion criteria
Exclusion criteria: Complicated with serious internal and external diseases, such as blood system diseases; v those who have no fertility requirements and require surgical hysterectomy; v second primary cancer in other parts at the time of diagnosis; v cases with incomplete pathological and follow-up data and extensive systemic metastasis; v participating in or having participated in any other clinical trials in the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Human chorionic gonadotropin;Course of treatment required for CR; | — |
Countries
China